| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 64.84B | 66.06B | 64.69B | 60.74B | 54.78B | 48.00B |
| Gross Profit | 14.51B | 14.47B | 13.99B | 11.09B | 10.48B | 9.74B |
| EBITDA | 7.27B | 7.41B | 7.00B | 4.81B | 4.68B | 4.51B |
| Net Income | 4.99B | 4.94B | 3.95B | 2.10B | 1.30B | 1.30B |
Balance Sheet | ||||||
| Total Assets | 83.79B | 85.24B | 87.46B | 82.03B | 79.79B | 75.50B |
| Cash, Cash Equivalents and Short-Term Investments | 16.29B | 16.23B | 15.89B | 10.87B | 8.95B | 6.54B |
| Total Debt | 4.10B | 3.53B | 3.98B | 7.38B | 8.85B | 9.29B |
| Total Liabilities | 21.53B | 21.13B | 27.89B | 29.82B | 30.06B | 28.34B |
| Stockholders Equity | 56.30B | 57.46B | 53.40B | 46.19B | 44.27B | 42.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.72B | 8.07B | 3.91B | 2.78B | -2.07B |
| Operating Cash Flow | 0.00 | 3.12B | 9.32B | 6.20B | 5.02B | 3.08B |
| Investing Cash Flow | 0.00 | -1.24B | 533.00M | -1.59B | -1.27B | -5.64B |
| Financing Cash Flow | 0.00 | -2.04B | -5.09B | -2.82B | -1.70B | 1.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥44.20B | 8.18 | ― | 5.04% | -3.56% | 36.27% | |
74 Outperform | ¥159.36B | 8.76 | 6.23% | 1.11% | 2.66% | -20.98% | |
74 Outperform | ¥35.19B | 15.61 | ― | 3.70% | 21.29% | 38.48% | |
69 Neutral | ¥2.28T | 13.66 | 11.64% | 1.52% | 8.27% | 41.40% | |
69 Neutral | ¥555.73B | 23.07 | ― | 3.26% | 15.83% | 124.18% | |
68 Neutral | ¥392.79B | 7.90 | 13.71% | 3.38% | 0.30% | -14.75% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |